Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Chidamide and decitabine can synergistically induce apoptosis of Hodgkin lymphoma cells by up-regulating the expression of PU.1 and KLF4

Published:2017-09-06 Issue:44 Volume:8 Page:77586-77594
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Jiang Tao¹²,Wang Fujue¹³,Hu Lianjie¹³,Cheng Xiaomin¹⁴,Zheng Yuhuan¹³,Liu Ting¹³,Jia Yongqian¹³

Affiliation:

1. Department of Hematology, West China Hospital of Sichuan University, Chengdu 610041, Sichuan, China

2. Department of Hematology, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu 610072, Sichuan, China

3. Laboratory of Hematology, West China Hospital of Sichuan University, Tianfu Life Science Park, Chengdu 610041, Sichuan, China

4. Department of Hematology, Chengdu Military General Hospital, Chengdu 610083, Sichuan, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chidamide suppresses adipogenic differentiation of bone marrow derived mesenchymal stem cells via increasing REEP2 expression;iScience;2023-03

2. Therapeutic potential of tucidinostat, a subtype-selective HDAC inhibitor, in cancer treatment;FRONT PHARMACOL;2022

3. PU.1 is involved in the transcriptional up-regulation of RNA and DNA sensing pathway genes in buffalo fibroblasts;Veterinary Immunology and Immunopathology;2021-12

4. Chidamide inhibits the NOTCH1-MYC signaling axis in T-cell acute lymphoblastic leukemia;Frontiers of Medicine;2021-10-20

5. Chidamide triggers BTG1-mediated autophagy and reverses the chemotherapy resistance in the relapsed/refractory B-cell lymphoma;Cell Death & Disease;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3